Patricia L. Wadors - 26 Feb 2026 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Feb 2026, 18:43:32 UTC
Prior SEC filing
05 Feb 2026
Next SEC filing
13 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Stephanie Lim-Ignacio For: Wadors, Patricia

Key filing fact

Patricia L. Wadors filed Form 4 for INTUITIVE SURGICAL INC (ISRG) on 27 Feb 2026.

Key facts

  • This page summarizes Patricia L. Wadors's Form 4 filing for INTUITIVE SURGICAL INC (ISRG).
  • 5 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 27 Feb 2026, 18:43.

Change

  • Previous filing in this sequence was filed on 05 Feb 2026.
  • Current net transaction value: -$230,405.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001274559 Primary reporting owner

WADORS PATRICIA L

Relationship
SVP Chief Human Resources Offi
Address
1020 KIFER ROAD, SUNNYVALE
Signature
By: Stephanie Lim-Ignacio For: Wadors, Patricia
Signature date
27 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ISRG transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+458
Change %
Price
$0.000000
Shares after
458
Date
26 Feb 2026
Ownership
Direct
Footnotes
F1
ISRG transaction

Common Stock

Tax liability

Transaction value
$120,468
Shares
-238
Change %
-52%
Price
$506.17
Shares after
220
Date
26 Feb 2026
Ownership
Direct
Footnotes
F1
ISRG transaction

Common Stock

Sale

Transaction value
$109,936
Shares
-220
Change %
-100%
Price
$499.71
Shares after
0
Date
27 Feb 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ISRG transaction Derivative

Restricted Stock Units - 2-26-2025

Options Exercise

Transaction value
$0
Shares
-458
Change %
-25%
Price
$0.000000
Shares after
1,373
Date
26 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
458
Exercise price
$0.000000
Footnotes
F3
ISRG transaction Derivative

Restricted Stock Units - 2-26-2026

Award

Transaction value
$0
Shares
+3,584
Change %
Price
$0.000000
Shares after
3,584
Date
26 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,584
Exercise price
$0.000000
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Footnote F2

The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 5, 2026.

Footnote F3

Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .